NCT01506258.

Study name	Autologous stem cells in newborns with oxygen deprivation
Methods	a open‐labelled non‐randomised interventional study with parallel assignment
Participants	Infants between 37 to 42 weeks of GA. Inclusion criteria Apgar < 5 at 5 minutes Mixed or metabolic acidosis with a pH < 7.0 from umbilical cord blood sample Neurological manifestations compatible with hypoxic‐ischemic encephalopathy Any degree of organic/systemic affectation (cardiovascular, gastrointestinal, haematologic and/or respiratory)
Interventions	IV infusion of autologous cord and placental cord blood Comparison group: control group of patients that meet the inclusion criteria but that do not wish to have the intervention.
Outcomes	Primary outcomes Effects of stem cell infusion at 1 week and 1 year after discharge: clinical assessment, including the Amiel‐Tison Neurological Assessment Secondary outcomes: not nominated.
Starting date	January 2012
Contact information	Principal Investigator: Consuelo Mancias‐Guerra, MD; Hospital Universitario Dr. Jose E. Gonzalez Study Director: Alma R Marroquin‐Escamilla, MD; Hospital Universitario Dr. Jose E. Gonzalez Study Chair: David Gómez‐Almaguer, MD; Hospital Universitario Dr. Jose E. Gonzalez
Notes	Study sponsor: Hospital Universitario Dr. Jose E. Gonzalez